医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

8th Annual OneMedForum San Francisco Expands Its China Forum into Partnering Conference, January 14-15

2014年12月04日 AM01:52
このエントリーをはてなブックマークに追加


 

NEW YORK

OneMedForum announced today that its 8th annual OneMedForum conference, to be held at the San Francisco Marriott Marquis, Jan. 12-13, 2015, will expand its annual China Forum event at the same venue on Jan. 14-15, 2015. This separate partnering event will connect strategic and financial investors from China with emerging growth companies in the healthcare and life sciences sector.

Register and learn more: www.onemedchina.com

“We are pleased to be transitioning from the education sessions that we’ve done over the past four years into facilitating actual transactions. China represents an extraordinary opportunity for our healthcare companies both as of source of capital and distribution,” said Brett Johnson, Founder of OneMedForum. “This development is the result of a joint venture between OneMedMarket and The Pharma Partners of Hong Kong (TPP). We have identified over 50 investment groups, each with at least $10 million USD allocated to license or acquire technologies, products, and companies in 2015. Many will be attending in San Francisco and virtually all will be at our follow-up meeting in Shanghai in the second quarter of 2015.”

“Our goal is to identify companies that would be most relevant and successful in China. We expect many companies presenting at OneMedForum to participate,” added Johnson. “China Forum’s primary focus will be on companies with products that are currently approved or very near commercialization.”

TPP is a consulting company comprised of pharma and healthcare veterans with extensive networks within China’s healthcare sector. “We were seeking a partner to help identify investments appropriate to China,” said Tony Chu, Co-founder of TPP and President of Eastar Industries, a leading provider of chemicals to the pharmaceutical sector in China. “The network of companies built by OneMedPlace and the success of OneMedForum made them our first choice when seeking a U.S. partnership,” said Mr. Chu.

Asa Cox, Co-founder of TPP and CEO of GenericPharma 2.0, stated, “For most Western companies, China is an untapped source of capital and distribution, yet nearly impossible to reach without Chinese partners. This new relationship and the China Forum platform can facilitate joint ventures, distribution agreements, and direct investment in promising companies.”

Companies invited to participate will be have their executive summaries translated into Mandarin for distribution through Chinese investors in order to schedule productive face-to-face meetings before both the OneMedForum and China Forum partnering conferences. Companies interested in learning more should visit www.onemedchina.com.

CONTACT

Ronald Trahan Associates Inc.
Ronald Trahan, APR, +508-359-4005,
x108

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Brightree发布面向居家医疗器械的首个患者App
  • Brightreeが初のHME向け患者アプリを発表
  • Takeda to Present Results from Phase 3 ALTA-1L Trial Highlighting Intracranial Efficacy of ALUNBRIG® (brigatinib) Versus Crizotinib in First-Line Advanced ALK+ Non-Small Cell Lung Cancer
  • ポットネットワーク・ホールディングスがSEC報告会社登録に基づきPCAOB監査人による完全な監査・レビュー済みの財務報告書を公表
  • Takeda Receives Clearance from the Japan Fair Trade Commission for the Proposed Acquisition of Shire plc